Blinded By The Plight (Or By Global Pharma Healthcare)
T he FDA has stated that the public should refrain from buying EzriCare Artificial Tears, as the product has been recalled. Why? Global Pharma Healthcare decided that since the supposedly contaminated eye drops were found to be associated with potential blindness or death, they would get ahead of the problem while they could. Not the problem of the drug-resistant outbreak of Pseudomonas aeruginosa bacteria, but the PR problem.
If you shop for a healthcare system-related book, you'll find that the PR problem has been one of the few times when medical corporations seem to find it in their bank accounts to do better for the people. If you check out my blogs and my nonfiction bookstore online, you'll see why the name Andy Lazris has been so interwoven in controversy. Since I'm not a capitalist machine, I don't take the time to do damage control, and since most of my fiction and nonfiction books are about medicine, I share a lot of bad news.
I've been practicing medicine for over two decades, and sadly, there isn't a lot of good news that isn't immediately overwhelmed by the day's losses. If you browse my online fiction bookstore, you can buyThe Geriatric Vengeance Clubonline and my own take on how our blessed healthcare system treats vulnerability. As a potential patient of the American medical industry, you should know that it won't take much for your so-called carers to take you down to the market and swap you for some magic beans.
If You Value Human Life Say Eye!
A s a capitalist company, Global Pharma Healthcare's primary concern has to be how they're seen by consumers, not whether consumers can see. The problem was discovered in February of 2023, and since then, other manufacturers have coincidentally had the same problem. Pharmedica USA has recalled eye drops that were sold globally, although there've been no associated illnesses. The Apotex Corporation faced the dreaded but not uncommon recall because there were cracks in the bottle caps. These are only a few of the series, and unless significant monetary losses are trending, it would seem that there's more to the story.
Sadly, the truth is far more disappointing than a high-level conspiracy. Unless you consider industry-wide negligence a scandal because most wouldn't. Shop for a healthcare reform book, and it's clear that the priorities have always been in the profit margins, with humanitarian interests being a subsection under reputation management. The cluster of problems hasn't just arisen; it's only just become a problem. What's clear is that all these pharmaceutical companies have been operating at substandard levels for who knows how long, and now that Global Pharma Healthcare has a death on its headlines, there's a scramble to avoid meeting the same fate.
Of course, you don't need to read a history book to know that it doesn't take long for the public to go back to turning a blind eye. Still, absorbing losses from a recall is easy for a company than settling lawsuits. So as the math dictates, preserving consumer health has bobbed up to the top of the list of big pharma's concerns, and all it took was some exploration into loss of vision and death. Not exactly an eye for an eye, but at the very best, we can hope for a temporary mindfulness of sanitation.
If You're Healthy And You Know It, Stay Away
D id you know that in America, one of the causes of death you need to watch for is overtreatment? This is when doctors, overly enthusiastic about hiking up their villages prescribe and prescribe, with little care for what's needed. In these cases, being overly medicated and uncared for is detrimental to patient health, and they're ultimately worse off after seeking medical attention. If you check out my nonfiction book,Curing Medicare, you'll see that the industry is almost built to encourage this. To stay safe, you need a doctor who's willing to risk a malpractice suit to do right by you.
The striking part of the Artificial Tears drops is that they're over-the-counter drops for dry eyes. It's unlikely that the people who used them needed them. They simply trusted that a product made by a renowned company could only do good. That should be true, but if there's anything to be learned from our reality, it's that we should depend on healthcare as sparingly as possible. You'd probably be better off shopping for health benefit-related books and practicing home remedies.
I'm often in situations where I know better than what I'm mandated to do, but my hands are tied in a hundred-year-old policy. I could do as much as possible for a single patient, lose my license, and then be banished from the world of white coats forevermore. While it's not that bad of an outcome, it's also the end of a doctor's ability to do what little they can for every patient they have. It's an impossible decision. Do the most possible for one, or do a little for all? If you manage to find a decent doctor, keep in mind that so long as they're policed by the culture of commercialism, they can't prioritize your best interests. So while no one in their right mind would evade medical attention, it might be a good idea to think strongly about who you trust with your well-being.
Read Between The Headlines: It's Never An Eye-solated Incident
From the shock and awe in the news, you'd think that this unbelievable turnout, the fact that a prosperous organization could be to blame for a problem, is scandalous. That's something you need to learn to look past. With every calamity that seems to be ripped straight out of a dystopian medical fiction book, there'll be several precedents. This isn't the first drug to be approved by the FDA, distributed, and then cause some "unexplained deaths". In the medical world, that's not even a disaster, it's an oopsie daisy. These little faux pas are usually followed by some payouts and the flashy introduction of a new drug. Like a superhero, big pharma will swoop in to put out the very fire it started.
One of the most notable examples is Xarelto (rivaroxaban), an anticoagulant drug approved by the FDA in 2011 for preventing blood clots in patients with atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Xarelto works by inhibiting the activity of a protein called Factor Xa, which is involved in the blood clotting process.
However, Xarelto has been linked to serious bleeding events, including gastrointestinal bleeding, intracranial hemorrhage, and death. There have been thousands of lawsuits filed against the manufacturers of Xarelto, alleging, with evidence, that the drug was marketed without adequate warnings about the risks. It's still on the market, but the manufacturers have introduced a second drug to be taken in conjunction with it so that consumers can live to buy another pill.
This isn't a recent development in medicine. It predates the start of the century.
Another example is Vioxx (rofecoxib), a nonsteroidal anti-inflammatory drug (NSAID) that was approved by the FDA in 1999 for treating pain and inflammation. Vioxx was highly effective in relieving pain, but it was later discovered that the drug increased the risk of heart attacks and strokes. In 2004, the manufacturer voluntarily withdrew Vioxx from the market after a study found that the drug was responsible for more bad than good.
Finally, Avandia (rosiglitazone) is a medication used to treat type 2 diabetes by helping to control blood sugar levels. Avandia was approved by the FDA in 1999 and quickly became a popular medication for the treatment of diabetes. However, in 2007, a study published in the New England Journal of Medicine found that Avandia increased the risk of heart attacks and other cardiovascular events. In response to the study, the FDA required that Avandia carry a black box warning, the strongest warning the agency can require.
You could even check out a COVID-19 bookstore to see how obviously that vaccine was a little better than some guesswork, lots of money, and ultimately a shot in the dark.
As the author of Three Brothers from Virginia and The Adventures of Yadel the Dreidel, I know that humankind has a long way to go, but where healthcare is concerned, we reach new heights of failure every day.
purchase 3D Fictional book online if you want to investigate this without the subtlety. Visit the Andy Lazris online fiction book shop to buy The Great Stupidity. The book comes with custom soundtracks, adding a multimedia element to your reading experience.
Pop into the online bookstore to buy affordable non fiction books online about the American healthcare system, or tune into my podcast to find out more about what inspires my catchy tunes and blog updates.